Design
Review
Authors
Loading...
Potential metabolic targets in cardiac disease identified; leaves open clinical validation of PPAR/PGC-1 modulation.
Key points are not available for this paper at this time.
Huss et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: